Join the club for FREE to access the whole archive and other member benefits.

Eran Elinav

Fellow of Humans & the Microbiome at Weizmann Institute of Science.

The Elinav lab studies the microbiome, the immense microbial ecosystem that resides within the mammalian intestine and in other mucosal surfaces.

This microbial community is dominated by bacteria, but also includes archaea, eukarya and viruses. The Elinav group aims to decode how the vast microbiome repertoire functions in ways that benefit the host. The gut microbiome is shaped and regulated by multiple factors including our genomic composition, the local intestinal niche, and multiple environmental factors such as our nutritional repertoire and bio-geographical location. The mucosal immune system, as one example, co-evolves with the microbiome from birth, and intimately interacts with it through multiple mechanisms that remain elusive to date. Importantly, it has been recently highlighted that dysregulation of a number of genetic or environmental factors leads to aberrant host-microbiome interactions, ultimately predisposing the host to diseases including chronic inflammation, obesity, the metabolic syndrome and cancer.

Visit website: https://www.weizmann.ac.il/immunology/elinav/group

 ElinavLabOfficial

 eran-elinav-1a87bb1b

 EranElinav

See also: Institute Weizmann Institute of Science - Public Research university.

Details last updated 15-Jan-2020

Eran Elinav News

The integral role of gut microbiome in precision medicine

AACC (American Association for Clinical Chemistry) - 01-May-2020

Huge potential in a more personalized diagnostics and diet-based disease interventions

Read more...

Probiotics inhibit microbiome recovery after antibiotics

Guardian - 06-Sep-2018

They cause severe and long-lasting disturbances over gene expression and native microbiome

Read more...

A Personalized Diet, Better Suited to You

New York Times - 11-Jan-2016

Each of us is unique in the way we absorb and metabolize nutrients. Nutritional advice should be...

Read more...